Some visit links earn us a commission.

Ozempic vs Wegovy cost: both $349 a month and up

Prices checked November 16, 2026

No insurance needed. Two programs to check.

Ozempic and Wegovy hold the same medicine, semaglutide, made by Novo Nordisk, and paying cash both pens start at $349 a month at NovoCare. The difference is the label. Ozempic is approved for type 2 diabetes and Wegovy for weight loss, and that one line decides whether a plan pays.

Ozempic vs Wegovy, side by side

Ozempic and Wegovy compared on medicine, approval, cash price, savings card, Medicare and doses
OzempicWegovy
Medicine
SemaglutideSemaglutide
Sold for cash by
NovoCare (Novo Nordisk)NovoCare (Novo Nordisk)
Approved for
Type 2 diabetes. Also lowers heart and kidney risk in people with type 2 diabetesWeight loss. Also lowers heart risk in people with heart disease, and treats a fatty liver disease
Cash price
$349 to $499 a month by dose$349 a month for the pen and $399 for the 7.2 mg HD pen
Savings card, with commercial insurance
As low as $25/mo (max $100/mo off)As low as $25/mo (max $100/mo off)
Medicare GLP-1 Bridge
Not included$50 a month
Doses
0.5 mg, 1 mg or 2 mg, based on glycemic control. Highest dose 2 mg weekly1.7 mg or 2.4 mg, with 2.4 mg marked recommended. Highest dose 7.2 mg weekly

Cash prices are the makers' own, checked November 16. You need a prescription for either.

Why both start at the same cash price

NovoCare is Novo Nordisk's own cash pharmacy, and it sells both pens. Ozempic is $349 to $499 a month by dose. Wegovy is $349 a month for the pen and $399 for the 7.2 mg HD pen. You need a prescription either way, and NovoCare does not bill insurance.

Both brands also come as a daily pill at NovoCare, priced on Wegovy pill cost and Ozempic pill cost. Every pen figure by dose: Wegovy cost and Ozempic cost.

What insurance does with each

Plans pay for Ozempic when you have type 2 diabetes, often after prior approval, and Medicare Part D covers it for diabetes too. A plan that excludes weight loss drugs can still cover Ozempic for diabetes, which is why the two names get confused at the pharmacy counter.

Wegovy is covered only where a plan includes weight loss, usually after prior approval. Medicare does not pay for weight loss alone, but it covers Wegovy to lower heart risk, and its GLP-1 Bridge charges $50 a month for Wegovy to people who qualify, from July 1, 2026 to December 31, 2027. The Bridge does not include Ozempic.

Both makers' savings cards need commercial insurance that covers the drug. On Ozempic the card terms read as low as $25/mo (max $100/mo off); on Wegovy, as low as $25/mo (max $100/mo off). Neither works with Medicare or Medicaid.

Doses and how you take them

Both are a pen you use once a week. Ozempic stays at 0.5 mg, 1 mg or 2 mg, chosen for blood sugar. Wegovy climbs to 1.7 mg or 2.4 mg, and its label now allows a 7.2 mg dose, sold as the Wegovy HD pen.

The higher Wegovy doses are the reason the two are not interchangeable at the counter: an Ozempic prescription cannot be filled as Wegovy, or the reverse. Your prescriber picks the brand and the dose.

Questions people ask

Is Ozempic cheaper than Wegovy?
Not on cash price. At NovoCare both pens start at $349 a month; Ozempic's top dose is $499 and the Wegovy HD pen $399. With diabetes and insurance, Ozempic is the one more plans cover.
Are Ozempic and Wegovy the same drug?
Both are semaglutide from Novo Nordisk, given once a week. Ozempic is approved for type 2 diabetes and Wegovy for weight loss, and Wegovy goes to higher doses.
Does Medicare cover Ozempic or Wegovy?
Medicare Part D covers Ozempic for type 2 diabetes. It does not cover Wegovy for weight loss alone, but covers it to lower heart risk, and the GLP-1 Bridge charges $50 a month for Wegovy to people who qualify.
Is there a savings card for Ozempic and Wegovy?
Yes, for people with commercial insurance that covers the drug. Ozempic: as low as $25/mo (max $100/mo off). Wegovy: as low as $25/mo (max $100/mo off). Neither card works with Medicare or Medicaid.

Compare other GLP-1 medications

Sources

Evidence checked November 9, 2026

Every figure above is taken from the document beside it, the FDA label or the trial that produced it, so you can read the source instead of trusting us. How we check sources.

2 documents

  1. What Ozempic is approved for and its dosesFDA prescribing information for Ozempic injection (DailyMed, revised June 2026)
  2. What Wegovy is approved for and its dosesFDA prescribing information for Wegovy, injection and tablets (DailyMed, revised June 2026)

Prices from NovoCare and LillyDirect and the makers' savings card pages, checked November 16. How we check prices.